Contact allergic dermatitis and periocular depigmentation after using olapatidine eye drops.
Suchi
Smitha T
ST
Gupta
Arvind
A
Srinivasan
Renuka
R
D000328:Adult; D001548:Benzalkonium Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D017449:Dermatitis, Allergic Contact / Q000209:etiology* / Q000473:pathology; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D009883:Ophthalmic Solutions
D001548:Benzalkonium Compounds; D006634:Histamine H1 Antagonists; D009883:Ophthalmic Solutions